| 000 | 01804 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513194342.0 | ||
| 264 | 0 | _c19991202 | |
| 008 | 199912s 0 0 eng d | ||
| 022 | _a0277-1691 | ||
| 024 | 7 |
_a10.1097/00004347-199910000-00003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCohen, I | |
| 245 | 0 | 0 |
_aEndometrial cancers in postmenopausal breast cancer patients with tamoxifen treatment. _h[electronic resource] |
| 260 |
_bInternational journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists _cOct 1999 |
||
| 300 |
_a304-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAdenosarcoma _xdiagnosis |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma _xdiagnosis |
| 650 | 0 | 4 | _aDemography |
| 650 | 0 | 4 |
_aEndometrial Neoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aEndometrium _xpathology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms, Second Primary _xdiagnosis |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aTamoxifen _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aUterine Hemorrhage _xdiagnosis |
| 700 | 1 | _aAzaria, R | |
| 700 | 1 | _aFishman, A | |
| 700 | 1 | _aTepper, R | |
| 700 | 1 | _aShapira, J | |
| 700 | 1 | _aBeyth, Y | |
| 773 | 0 |
_tInternational journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists _gvol. 18 _gno. 4 _gp. 304-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004347-199910000-00003 _zAvailable from publisher's website |
| 999 |
_c10499682 _d10499682 |
||